Literature DB >> 27559630

Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system.

Daniel Blessing1, Nicole Déglon2.   

Abstract

The last two decades have witnessed the increasing instrumentalization of viruses, which have progressively evolved into highly potent gene transfer vehicles for a wide spectrum of applications. In the context of the central nervous system (CNS), their unique gene delivery features and targeting specificities have been exploited not only to improve our understanding of basic neurobiology, but also to investigate diseases or deliver therapeutic candidates. As a result, we have started moving away from the opportunistic use of recombinant vectors that are derived from naturally existing viruses toward the rational engineering of tailored lentivirus (LV) and adeno-associated virus (AAV) vectors for specific use in the CNS. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27559630     DOI: 10.1016/j.coviro.2016.08.004

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  10 in total

Review 1.  Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair.

Authors:  Justin L Madrigal; Roberta Stilhano; Eduardo A Silva
Journal:  Tissue Eng Part B Rev       Date:  2017-03-10       Impact factor: 6.389

2.  Viral Vector-Based Evaluation of Regulatory Regions in the Neuron-Specific Enolase (NSE) Promoter in Mouse Cerebellum In Vivo.

Authors:  Yoichiro Shinohara; Toshinori Ohtani; Ayumu Konno; Hirokazu Hirai
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

Review 3.  Gene-Modified Stem Cells for Spinal Cord Injury: a Promising Better Alternative Therapy.

Authors:  Yirui Feng; Yu Li; Ping-Ping Shen; Bin Wang
Journal:  Stem Cell Rev Rep       Date:  2022-05-19       Impact factor: 5.739

4.  A MicroRNA-Based Gene-Targeting Tool for Virally Labeling Interneurons in the Rodent Cortex.

Authors:  Marianna K Keaveney; Hua-An Tseng; Tina L Ta; Howard J Gritton; Heng-Ye Man; Xue Han
Journal:  Cell Rep       Date:  2018-07-10       Impact factor: 9.423

Review 5.  Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Aβ in the Central Nervous System.

Authors:  Joel N Buxbaum; Jan Johansson
Journal:  Front Neurosci       Date:  2017-03-15       Impact factor: 4.677

6.  Adeno-Associated Viral Vectors Serotype 8 for Cell-Specific Delivery of Therapeutic Genes in the Central Nervous System.

Authors:  Diego Pignataro; Diego Sucunza; Lucia Vanrell; Esperanza Lopez-Franco; Iria G Dopeso-Reyes; Africa Vales; Mirja Hommel; Alberto J Rico; Jose L Lanciego; Gloria Gonzalez-Aseguinolaza
Journal:  Front Neuroanat       Date:  2017-02-10       Impact factor: 3.856

7.  Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington's Disease.

Authors:  Minhee Jang; Seung Eun Lee; Ik-Hyun Cho
Journal:  Front Cell Neurosci       Date:  2018-06-12       Impact factor: 5.505

8.  Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice.

Authors:  Bao-Shu Xie; Xin Wang; Yao-Hua Pan; Gan Jiang; Jun-Feng Feng; Yong Lin
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

9.  Adeno-associated virus 2/9 delivery of Cre recombinase in mouse primary afferents.

Authors:  Khaled Abdallah; Francis Nadeau; Francis Bergeron; Sylvie Blouin; Véronique Blais; Kelly M Bradbury; Christine L Lavoie; Jean-Luc Parent; Louis Gendron
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

Review 10.  Gene Therapy for ALS-A Perspective.

Authors:  Marisa Cappella; Chiara Ciotti; Mathilde Cohen-Tannoudji; Maria Grazia Biferi
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.